Similar Articles |
|
The Motley Fool December 19, 2011 Dan Caplinger |
Star Scientific Had a Great 2011 With Star Scientific looking to emphasize dissolvable tobacco and developing a process to cure tobacco in a non-carcinogenic way, investors could see the stock as the best way to play the industry. |
The Motley Fool July 28, 2011 |
1 Semiconductor Equipment Stock to Avoid Our investing community's latest prime pick: Aixtron. |
The Motley Fool January 17, 2012 Dan Caplinger |
What 2012 Has in Store for Star Scientific Let's look at this year's prospects for this company. |
The Motley Fool December 21, 2011 Austin Smith |
Star Scientific: 2012 Preview While regulations persisted throughout the year, providing a headwind for big tobacco, and a theoretical tail wind for Star Scientific, the company has failed to make a large dent in the smokeless tobacco space. |
The Motley Fool June 1, 2011 |
Avoid This Stock Like Bad Coffee Our investing community's latest stock to avoid is JAMMIN JAVA, which is extremely over-caffeinated at current levels. |
The Motley Fool September 29, 2010 |
A Blue Chip Priced for 20% Annual Returns Dell is a major blue chip company is priced to deliver 20% annual returns. |
The Motley Fool April 13, 2011 |
Strike a Gusher Shorting Oil Our investing community's latest short pick: U.S. Oil Fund. |
The Motley Fool April 21, 2011 Andrew Tonner |
Does Star Scientific Deserve a Spot in Your Portfolio? A quick check of the consumer products manufacturer's numbers should help get us started. |
The Motley Fool February 23, 2011 |
Our Top Short Idea Our investing community's latest prime pick -- Short iShares FTSE/Xinhua China 25 Index. |
The Motley Fool November 28, 2011 Dan Newman |
Tobacco: The Negative Cash Flow Crop Star Scientific punishes shareholder value in order to stay afloat. |
The Motley Fool January 20, 2012 Austin Smith |
Earnings Preview: What to Expect From Big Tobacco Make sure to stay tuned when these tobacco companies report earnings. |
The Motley Fool August 25, 2011 Neha Chamaria |
Star Scientific's Unstellar Performance Star Scientific posts losses in its second quarter; outlook remains grim. |
The Motley Fool November 5, 2011 Anand Chokkavelu |
Better Buy: Altria or Philip Morris? Today's matchup is the Civil War of Big Tobacco. Brother goes up against brother as we pit Altria and Philip Morris International. |
The Motley Fool June 15, 2010 Julie Clarenbach |
Is This the Best Tobacco Buy? Who are the major tobacco retailers and how do they stack up to one another? |
The Motley Fool October 18, 2011 Austin Smith |
Earnings Season Preview: These Tobacco Stocks Are Big on Dividends, but What About Earnings? Here is what to expect from everyone's love-to-hate industry this earnings season. |
The Motley Fool July 31, 2008 Colleen Paulson |
Altria Exhales Growth Cost control and market-share growth drive an adjusted earnings gain. |
The Motley Fool December 15, 2008 Rich Smith |
This Just In: Upgrades and Downgrades JPMorgan Securities upgrades Altria to a "buy." |
The Motley Fool September 30, 2010 Rich Smith |
This Just In: Upgrades and Downgrades Another analyst calls it quits on Altria. |
The Motley Fool October 19, 2010 Rich Smith |
This Just In: Upgrades and Downgrades Credit Suisse started Philip Morris shares at "outperform" ahead of Thursday's earnings. |
The Motley Fool May 27, 2011 Jim Royal |
Big Tobacco's Been Busy Look at these recent acquisitions by British American Tobacco and Philip Morris. |
The Motley Fool October 27, 2011 Jim Royal |
I Can't Quit You, Big Tobacco Big Tobacco is being hit by challenges across the spectrum -- lawsuits, declining smoking rates, and new packaging rules -- but some companies have been able to claim victories of a sort. |
The Motley Fool July 18, 2011 Jim Royal |
Big Tobacco Faces Another Huge Headwind More packaging changes could dent these players' profits. |
The Motley Fool November 10, 2009 Colleen Paulson |
Altria's Not Tobacco's Only Altruist Reynolds American may purchase a quit-smoking company. |
The Motley Fool November 22, 2011 Austin Smith |
Big Tobacco Turns the Tables In an industry rife with lawsuits, Philip Morris tries on the other shoe. |
The Motley Fool January 7, 2010 Colleen Paulson |
Big Tobacco Is Back to Business Philip Morris USA touts "lower risk" smokeless tobacco. |
The Motley Fool January 5, 2011 Dan Dzombak |
This Company Could Go to Zero Lorillard faces 90% of its cigarette products being banned. |
InternetNews December 13, 2010 |
Judge Dismisses Allen's Massive Patent Lawsuit In a setback for Microsoft co-founder Paul Allen, a federal judge has dismissed his patent lawsuit charging eight prominent technology companies with infringement, though he is eligible to refile. |
The Motley Fool April 26, 2006 Tim Beyers |
Who's Buying Now? Sometimes, insiders are buying for all the right reasons. Who's at it this week? Cash Systems... Imation... Matria Healthcare... Star Scientific... Tortoise North American Energy... |
The Motley Fool December 21, 2004 Chris Mallon |
End of the Legal Tunnel An improving legal environment makes Altria's shares look extremely undervalued. |
The Motley Fool October 22, 2009 Colleen Paulson |
Is Philip Morris Lost in Translation? Unfavorable currency exchange and volume declines hit earnings. |
The Motley Fool June 9, 2011 Neha Chamaria |
How Big Tobacco's Trying to Regain Lost Ground in the U.S. Reynolds counters expanded smoking bans with its Camel Snus campaign. |
The Motley Fool October 11, 2011 Dan Caplinger |
Has Altria Become the Perfect Stock? With a modest rise in share prices even before considering a dividend yield remaining near 6%, Altria has given shareholders a perfect combination of income and capital gains over the past year. |
The Motley Fool January 18, 2011 Jim Royal |
How Does Big Tobacco Really Make Its Money? Breaking down a company's return on equity can often give you some insight into how it's competing against peers and what type of strategy it's using to juice its return on equity. |
The Motley Fool July 22, 2009 Colleen Paulson |
Smokin' Hot Growth for Altria? Altria increases guidance with 8.7% quarterly EPS growth. |
The Motley Fool December 19, 2011 Rebecca Lipman |
Cigarette Stocks: The Myth of the Dying Tobacco Industry Do you think these names have the momentum to continue on an upward trend? |
The Motley Fool August 2, 2010 Anand Chokkavelu |
Why We're Buying Altria Due to smoking bans and health consciousness, cigarette usage in the U.S. is on the way down at a rate of 3%-4% a year. |
The Motley Fool October 30, 2009 Mike Pienciak |
2 Big Reasons To Buy Philip Morris International A steady dividend and relatively strong international markets bolster the "buy" case for Phillip Morris. |
The Motley Fool July 23, 2010 Jim Mueller |
Buy, Sell, or Hold Altria? Which position should you take? |
The Motley Fool November 1, 2011 Alex Dumortier |
Should Altria Be Buying Back Shares? The new buyback program is no buy signal. Altria's price-to-earnings multiple is in middle quintile relative to the companies in the S&P 500 and to its own five-year history. |
The Motley Fool April 20, 2011 Colleen Paulson |
Hazy Days Ahead for Altria? Altria's first quarter combines earnings growth with market share decline. |
The Motley Fool January 28, 2010 Colleen Paulson |
Altria's Stayin' Alive Altria delivers EPS growth in spite of a decline in cigarette volume. |
The Motley Fool September 30, 2010 Matt Koppenheffer |
How Much Is Altria Worth? Is Altria's stock on sale? |
The Motley Fool December 8, 2009 Rick Steier |
Altria: The Healthiest Stock Addiction Altria is a "forever hold" stock. |
BusinessWeek September 13, 2004 Nanette Byrnes |
Double Danger For Big Tobacco A U.S. Justice suit and a push for FDA oversight have cigarette makers gasping. |
The Motley Fool July 23, 2010 Colleen Paulson |
Altria Gets Its MO-jo Back Altria is smoking hot with its strong second-quarter results. |
Registered Rep. June 16, 2011 Jerry Gleeson |
Morningstar's New Rating System Gazes Beyond the "Stars" Looking to give advisors new measures for evaluating funds, Morningstar plans to release a new "forward-looking" rating tool that uses its analysts' expertise to evaluate the funds' ability to outperform their benchmarks. |
The Motley Fool September 11, 2009 Colleen Paulson |
Altria Blazes On The tobacco giant sets itself apart with new product plans. |
The Motley Fool August 2, 2011 Shubh Datta |
A Smoky Outlook for Lorillard Q2 results were respectable, but the next quarter could be weaker for cigarette maker Lorillard. |
The Motley Fool June 21, 2011 Jordan DiPietro |
Should You Buy and Hold Reynolds American? Reynolds has a beta of 0.7, which is pretty low. Generally speaking, I like to see a beta below 1.2 for retirees. In this case, Reynolds fits the bill. |
The Motley Fool May 13, 2011 Patrick Martin |
The Best Stock I Never Meant to Buy I picked a good stock, Philip Morris ... but not on purpose. |